Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Total Debt (2019 - 2023)

Korro Bio (KRRO) has disclosed Total Debt for 4 consecutive years, with $11.7 million as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Total Debt fell 22.22% year-over-year to $11.7 million, compared with a TTM value of $11.7 million through Mar 2023, down 22.22%, and an annual FY2022 reading of $14.2 million, down 5.55% over the prior year.
  • Total Debt was $11.7 million for Q1 2023 at Korro Bio, down from $14.2 million in the prior quarter.
  • Across five years, Total Debt topped out at $15.0 million in Q4 2020 and bottomed at $11.7 million in Q1 2023.
  • Average Total Debt over 4 years is $14.6 million, with a median of $15.0 million recorded in 2020.
  • The sharpest move saw Total Debt changed 0.0% in 2021, then dropped 22.22% in 2023.
  • Year by year, Total Debt stood at $15.0 million in 2020, then changed by 0.0% to $15.0 million in 2021, then fell by 5.55% to $14.2 million in 2022, then fell by 17.65% to $11.7 million in 2023.
  • Business Quant data shows Total Debt for KRRO at $11.7 million in Q1 2023, $14.2 million in Q4 2022, and $15.0 million in Q3 2022.